MedPath

Construction of a novel diagnostic technology by using metabolomics in patients with urological cancers

Not Applicable
Recruiting
Conditions
renal cancer, bladder cancer, prostate cancer, urothelial cancer
Registration Number
JPRN-UMIN000028290
Lead Sponsor
The University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of a novel marker for urologic cancers by using metabolomics
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath